218 related articles for article (PubMed ID: 331001)
1. The diagnosis and management of dapsone-resistant leprosy.
Waters MF
Lepr Rev; 1977 Jun; 48(2):95-105. PubMed ID: 331001
[No Abstract] [Full Text] [Related]
2. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of leprosy. Part 1.
Ellard GA
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
[No Abstract] [Full Text] [Related]
4. Leprosy.
Marcos LA; Conerly S; Walker S
Am J Trop Med Hyg; 2014 Aug; 91(2):216. PubMed ID: 25100789
[No Abstract] [Full Text] [Related]
5. The treatment of leprosy today and tomorrow: the LEPRA consultation on chemotherapy.
Browne SG
Lepr Rev; 1977 Dec; 48(4):283-6. PubMed ID: 400810
[No Abstract] [Full Text] [Related]
6. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
[No Abstract] [Full Text] [Related]
7. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
8. Leprosy and its chemotherapy.
Beeching NJ; Ellis CJ
J Antimicrob Chemother; 1982 Aug; 10(2):81-4. PubMed ID: 6749788
[No Abstract] [Full Text] [Related]
9. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
10. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
11. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
13. The treatment of leprosy.
Waters MF
Tubercle; 1983 Sep; 64(3):221-32. PubMed ID: 6356539
[No Abstract] [Full Text] [Related]
14. Dapsone resistance in leprosy.
Browne SG
Trans St Johns Hosp Dermatol Soc; 1973; 59(2):225-9. PubMed ID: 4602407
[No Abstract] [Full Text] [Related]
15. Clofazimine in the treatment of dapsone resistant leprosy.
Taylor PM; Alexander R
Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
17. Clinical assessment and management of dapsone-resistant leprosy for the field worker.
Warren G
Lepr Rev; 1977 Jun; 48(2):113-21. PubMed ID: 330996
[No Abstract] [Full Text] [Related]
18. Recent changes in leprosy control.
Sansarricq H
Lepr Rev; 1983 Jun; Spec No():7-16. PubMed ID: 6350774
[No Abstract] [Full Text] [Related]
19. Chemotherapy of leprosy in multibacillary nude mice.
Hastings RC; Chehl SK
Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
[No Abstract] [Full Text] [Related]
20. Evolution of the modern chemotherapy of leprosy.
Levy L
Lepr Rev; 1983 Jun; Spec No():69-83. PubMed ID: 6350773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
